MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.
about
The Role of MDM2 in Promoting Genome Stability versus Instability.Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets.TRIM31 regulates chronic inflammation via NF-κB signal pathway to promote invasion and metastasis in colorectal cancer.Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicineTargeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions
P2860
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@ast
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@en
type
label
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@ast
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@en
prefLabel
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@ast
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@en
P2093
P2860
P921
P1476
MDM2/X inhibitors under clinic ...... gnancies and pediatric cancer.
@en
P2093
Arianna Gonelli
Giorgio Zauli
Paola Secchiero
Rebecca Voltan
P2860
P2888
P356
10.1186/S13045-017-0500-5
P5008
P577
2017-07-03T00:00:00Z
P6179
1090274826